Ticker Details
OPKO Health, Inc. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products.
IPO Date:	November 2, 1995
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 2.99%
Avg Daily Range (30 D):	$0.05 | 3.38%
Avg Daily Range (90 D):	$0.03 | 2.57%

Institutional Daily Volume
Avg Daily Volume:	3.29M
Avg Daily Volume (30 D):	3.68M
Avg Daily Volume (90 D):	2.77M

Trade Size
Avg Trade Size (Sh.):	297
Avg Trade Size (Sh.) (30 D):	271
Avg Trade Size (Sh.) (90 D):	255

Institutional Trades
Total Institutional Trades:	4,530
Avg Institutional Trade:	$1.81M
Avg Institutional Trade (30 D):	$.66M
Avg Institutional Trade (90 D):	$1.08M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.99M
Avg Closing Trade (30 D):	$.66M
Avg Closing Trade (90 D):	$1.09M
Avg Closing Volume:	455.23K

News

Feb 12, 2026 @ 1:00 PM OPKO Health to Report Fourth Quarter 2025 Financia... Source: Na

Feb 4, 2026 @ 1:00 PM OPKO Health and Entera Bio Expand Partnership to A... Source: Opko Health, Inc. And Entera Bio Ltd.

Nov 18, 2025 @ 1:00 PM Entera Bio to Participate in the 8th Annual Everco... Source: Miranda Toledano

Oct 8, 2025 @ 12:02 PM NextPlat Issues CEO Shareholder Update Letter Source: David Phipps

Aug 8, 2025 @ 9:17 PM Entera Bio Beats Q2 EPS Estimates Source: Jesterai

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.09	$-.01	$-.07
Diluted EPS	$-.09	$-.01	$-.07
Revenue	$587.9M	$163.58M	$124.2M
Gross Profit	$239.69M	$80.02M	$45.76M
Net Income / Loss	$-72.89M	$-8.42M	$-54.85M
Operating Income / Loss	$-48.25M	$-6.97M	$-51.02M
Cost of Revenue	$348.2M	$83.56M	$78.44M
Net Cash Flow	$30.23M	$-40.99M	$-26.27M
PE Ratio